Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2010/091/000094
CTRI/2010/091/000094
Not yet recruiting
Phase 1

Is the use of bone marrow derived mononuclear cells safe and feasible in prevention of wound breakdown in patients undergoing abdominoperineal excision after neoadjuvant Chemoradiotherapy for Carcinoma Rectum ? a Pilot study

CMCH, Vellore0 sites20 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
CMCH, Vellore
Enrollment
20
Status
Not yet recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
CMCH, Vellore

Eligibility Criteria

Inclusion Criteria

  • •Patients diagnosed with carcinoma rectum undergoing Abdominoperineal excision following Long Course Chemoradiotherapy in Surgery Unit 5, using Conventional RT at 50\.4 Gy over 28 fractions.

Exclusion Criteria

  • •1\.Gross contamination intra op from Rectum or Urethra
  • •2\.Known immunosuppression
  • •3\. Patients who were diagnosed with hematological disease.
  • •4\. Patients receiving conformal radiotherapy

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 3
Autologous bone marrow-derived mononuclear cells for therapeutic arteriogenesis in patients with limb ischemia A double blind placebo controlled study in diabetic and non-diabetic patientsclaudication10003216
NL-OMON37216eids Universitair Medisch Centrum100
Completed
Phase 1
Autologous bone marrow derived mononuclear cells transplantation in idiopathic lower limb lymphedema patients
IRCT201611241031N19Royan Institute6
Completed
Phase 1
Intravenous autologous bone marrow mononuclear cell transplantation for cerebral embolismcerebral embolism
JPRN-UMIN000001133ational Cerbral and Cardiovascular Center12
Completed
Not Applicable
Bone marrow mononuclear cell implantation for patients with critical limb ischemiaPeripheral Arterial Disease (PAD) , Buerger disease, and arteritis associated with collagen diseases (Fontaines stage: III and IV)
JPRN-UMIN000021422BMI Study Group
Not yet recruiting
Phase 1
Effects of cell therapy and exosome in the treatment of amyotrophic lateral sclerosisAmyotrophic Lateral Sclerosis.Amyotrophic lateral sclerosisG12.21
IRCT20200904048610N1Mashhad University of Medical Sciences5